THEOREMS AND IMPLICATIONS OF A MODEL-INDEPENDENT ELIMINATION DISTRIBUTION FUNCTION DECOMPOSITION OF LINEAR AND SOME NONLINEAR DRUG DISPOSITIONS .2. CLEARANCE CONCEPTS APPLIED TO THE EVALUATION OF DISTRIBUTION KINETICS

被引:33
作者
GILLESPIE, WR [1 ]
VENGPEDERSEN, P [1 ]
机构
[1] UNIV IOWA,COLL PHARM,IOWA CITY,IA 52242
来源
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1985年 / 13卷 / 04期
关键词
D O I
10.1007/BF01061479
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:441 / 451
页数:11
相关论文
共 32 条
[1]   PHARMACOKINETICS OF CEFAMANDOLE USING A HPLC ASSAY [J].
AZIZ, NS ;
GAMBERTOGLIO, JG ;
LIN, ET ;
GRAUSZ, H ;
BENET, LZ .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1978, 6 (02) :153-164
[2]   PHARMACOKINETIC AND BIO-PHARMACEUTIC PROFILE OF CHLORDIAZEPOXIDE HCL IN HEALTHY SUBJECTS - SINGLE-DOSE STUDIES BY INTRAVENOUS, INTRAMUSCULAR, AND ORAL ROUTES [J].
BOXENBAUM, HG ;
GEITNER, KA ;
JACK, ML ;
DIXON, WR ;
SPIEGEL, HE ;
SYMINGTON, J ;
CHRISTIAN, R ;
MOORE, JD ;
WEISSMAN, L ;
KAPLAN, SA .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1977, 5 (01) :3-23
[3]   PHARMACOKINETICS OF INTRAVENOUS CHLORAMPHENICOL SODIUM SUCCINATE IN ADULT PATIENTS WITH NORMAL RENAL AND HEPATIC-FUNCTION [J].
BURKE, JT ;
WARGIN, WA ;
SHERERTZ, RJ ;
SANDERS, KL ;
BLUM, MR ;
SARUBBI, FA .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (06) :601-614
[4]   VARIABILITY IN DERIVED PARAMETERS OF FUROSEMIDE PHARMACOKINETICS [J].
CHENNAVASIN, P ;
JOHNSON, RA ;
BRATER, DC .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (05) :623-633
[5]   PHARMACOKINETICS OF THE PIVALOYLOXYETHYL (POE) ESTER OF METHYLDOPA, A NEW PRODRUG OF METHYLDOPA [J].
DOBRINSKA, MR ;
KUKOVETZ, W ;
BEUBLER, E ;
LEIDY, HL ;
GOMEZ, HJ ;
DEMETRIADES, J ;
BOLOGNESE, JA .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (06) :587-600
[6]   PHARMACOKINETICS OF CEFROXADIN (CGP 9000) IN MAN [J].
GERARDIN, A ;
LECAILLON, JB ;
SCHOELLER, JP ;
HUMBERT, G ;
GUIBERT, J .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1982, 10 (01) :15-26
[7]   PHARMACOKINETICS OF PROPRANOLOL IN NORMAL HEALTHY VOLUNTEERS [J].
GOMENI, R ;
BIANCHETTI, G ;
SEGA, R ;
MORSELLI, PL .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1977, 5 (03) :183-192
[8]   PHARMACOKINETICS AND BIOAVAILABILITY OF INTRAVENOUS, INTRAMUSCULAR, AND ORAL LORAZEPAM IN HUMANS [J].
GREENBLATT, DJ ;
SHADER, RI ;
FRANKE, K ;
MACLAUGHLIN, DS ;
HARMATZ, JS ;
ALLEN, MD ;
WERNER, A ;
WOO, E .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (01) :57-63
[9]   PHARMACOKINETIC COMPARISON OF SUB-LINGUAL LORAZEPAM WITH INTRAVENOUS, INTRAMUSCULAR, AND ORAL LORAZEPAM [J].
GREENBLATT, DJ ;
DIVOLL, M ;
HARMATZ, JS ;
SHADER, RI .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (02) :248-252
[10]   QUINIDINE PHARMACOKINETICS IN MAN - CHOICE OF A DISPOSITION MODEL AND ABSOLUTE BIOAVAILABILITY STUDIES [J].
GUENTERT, TW ;
HOLFORD, NHG ;
COATES, PE ;
UPTON, RA ;
RIEGELMAN, S .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1979, 7 (04) :315-330